Published in J Physiol on September 01, 1982
Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin. J Physiol (1983) 2.42
Mast cells and inflammation. Biochim Biophys Acta (2010) 1.91
Regulation of mast cell responses in health and disease. Crit Rev Immunol (2011) 1.50
Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell dependent. J Clin Invest (1989) 1.47
Biological evaluation of substance P antagonists. Br J Pharmacol (1984) 1.39
Histamine release and vascular changes induced by neuropeptides. Agents Actions (1983) 1.34
Histamine is released from skin by substance P but does not act as the final vasodilator in the axon reflex. Br J Pharmacol (1986) 1.27
Effect of inhaled substance P and neurokinin A on the airways of normal and asthmatic subjects. Thorax (1987) 1.20
Sensory neuropeptide effects in human skin. Br J Pharmacol (1987) 1.18
Studies on the trigeminal antidromic vasodilatation and plasma extravasation in the rat. J Physiol (1984) 1.13
Sialokinin I and II: vasodilatory tachykinins from the yellow fever mosquito Aedes aegypti. Proc Natl Acad Sci U S A (1994) 1.07
A study of [D-Pro2, D-Phe7, D-Trp9]-substance P and [D-Trp7,9]-substance P as tachykinin partial agonists in the rat colon. Br J Pharmacol (1984) 1.03
Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells. J Invest Dermatol (2011) 1.03
Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells. Br J Pharmacol (1988) 1.00
Tachykinins activate guinea-pig alveolar macrophages: involvement of NK2 and NK1 receptors. Br J Pharmacol (1990) 0.98
An examination of the pharmacology of two substance P antagonists and the evidence for tachykinin receptor subtypes. Br J Pharmacol (1986) 0.93
Effect of substance P on superoxide anion and IL-8 production by human PMNL. Immunology (1994) 0.89
The role of histamine in neurogenic inflammation. Br J Pharmacol (2013) 0.89
Plasma protein extravasation induced by mammalian tachykinins in rat skin: influence of anaesthetic agents and an acetylcholine antagonist. Br J Pharmacol (1987) 0.89
Spantide II, an effective tachykinin antagonist having high potency and negligible neurotoxicity. Proc Natl Acad Sci U S A (1990) 0.88
Neomycin is a potent secretagogue of mast cells that directly activates a GTP-binding protein involved in exocytosis. J Cell Biol (1990) 0.88
Role of peptidoleukotrienes in capsaicin-sensitive sensory fibre-mediated responses in guinea-pig airways. J Physiol (1991) 0.88
Phosphatidylcholine-specific phospholipase D-derived 1,2-diacylglycerol does not initiate protein kinase C activation in the RBL 2H3 mast-cell line. Biochem J (1992) 0.86
Blockade of mast cell histamine secretion in response to neurotensin by SR 48692, a nonpeptide antagonist of the neurotensin brain receptor. Br J Pharmacol (1995) 0.85
Chondroitin sulphate inhibits connective tissue mast cells. Br J Pharmacol (2000) 0.85
Apomorphine-induced inhibition of histamine release in rat peritoneal mast cells. Br J Pharmacol (1986) 0.83
Protein and diacylglycerol phosphorylation in the stimulus-secretion coupling of rat mast cells. Immunology (1987) 0.83
The involvement of sensory neuropeptides in toluene diisocyanate-induced tracheal hyperreactivity in the mouse airways. Br J Pharmacol (1996) 0.82
The demonstration of the cutaneous distribution of saphenous nerve C-fibres using a plasma extravasation technique in the normal rat and following nerve injury. J Anat (1988) 0.81
Calcitonin gene-related peptide (CGRP) activates human neutrophils--inhibition by chemotactic peptide antagonist BOC-MLP. Immunology (1992) 0.81
Effects of endogenous substance P expression on degranulation in RBL-2H3 cells. Inflamm Res (2010) 0.80
The release of leukotriene B4 from human skin in response to substance P: evidence for the functional heterogeneity of human skin mast cells among individuals. Clin Exp Immunol (2001) 0.77
Substance P-induced granulocyte infiltration in mouse skin: the mast cell-dependent granulocyte infiltration by the N-terminal peptide is enhanced by the activation of vascular endothelial cells by the C-terminal peptide. Clin Exp Immunol (1992) 0.77
Stress-induced mast cell activation in glabrous and hairy skin. Mediators Inflamm (2014) 0.76
Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells. J Pharmacol Exp Ther (2016) 0.76
The effect of adrenocorticotropin on histamine and 5-hydroxytryptamine secretion from rat mast cells. Agents Actions (1984) 0.75
Capsaicin-sensitive stretch responses in ferret trachealis muscle. J Physiol (1994) 0.75
The interaction of cholinomimetics, peptides and compounds 48/80 on histamine secretion from the mast cell. Agents Actions (1984) 0.75
Intradermal actions of hypertonic saline involve neural and vascular mechanisms. Br J Clin Pharmacol (1995) 0.75
A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther (1959) 16.61
Calcium ionophores and movement of calcium ions following the physiological stimulus to a secretory process. Nature (1973) 6.09
The role of the alkaline earth ions in anaphylactic histamine secretion. J Physiol (1972) 4.03
Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn Schmiedebergs Arch Pharmacol (1979) 3.80
The relationship between histamine secretion and 45calcium uptake by mast cells. J Physiol (1977) 3.02
Release of histamine from mast cells by vasoactive peptides. Proc Soc Exp Biol Med (1973) 2.38
Evidence for enzymatic histamine release from isolated rat mast cells. Exp Cell Res (1961) 2.15
Histamine release by compounds of simple chemical structure. Pharmacol Rev (1957) 1.82
The effect of phospholipids on anaphylactic histamine release. Br J Pharmacol (1972) 1.81
Flare and itch induced by substance P in human skin. J Invest Dermatol (1978) 1.72
Release of histamine by substance P. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.56
Role of intra- and extracellular calcium in histamine release from rat peritoneal mast cells. Agents Actions (1981) 1.53
The central and peripheral ends of the substance P-containing sensory neurones in the rat trigeminal system. Brain Res (1978) 1.52
Some studies on the release of histamine from mast cells stimulated with polylysine. Br J Pharmacol (1980) 1.45
Induction of histamine secretion by polycations. Biochim Biophys Acta (1980) 1.39
The action of lanthanum and manganese on anaphylactic histamine secretion. Br J Pharmacol (1973) 1.34
The pharmacological control of immediate hypersensitivity. Annu Rev Pharmacol Toxicol (1981) 1.33
The role of the N-terminal tetrapeptide in the histamine releasing action of substance P. Neuropharmacology (1981) 1.31
Noncytotoxic IgE-mediated release of histamine and serotonin from murine mastocytoma cells. J Immunol (1977) 1.22
Inhibition of antidromic and substance P-induced vasodilatation by a substance P antagonist. Acta Physiol Scand (1981) 1.16
Ionophore A-23187 induced histamine release from rat mast cells and rat basophil leukemia (RBL-1) cells. J Immunol (1975) 1.09
Synthetic peptides comprising sequences of the human immunoglobulin E heavy chain capable of releasing histamine. Biochem J (1979) 1.09
Postocclusive cutaneous vasodilatation mediated by substance P. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.05
Further observations on the inhibition of histamine release by 2-deoxyglucose. Acta Physiol Scand (1968) 1.02
A synthetic peptide as an antagonist of substance P. Nature (1981) 1.01
Assay and partial characterization of the solubilized cell surface receptor for immunoglobulin E. J Biol Chem (1977) 1.00
Relative activities of substance P-related peptides in the guinea-pig ileum and rat parotid gland, in vitro. Br J Pharmacol (1982) 0.96
The effects of substance P and related peptides on alpha-amylase release from rat parotid gland slices. Br J Pharmacol (1981) 0.91
Synthesis of granuliberin-R and various fragment peptides and their histamine-releasing activities. Chem Pharm Bull (Tokyo) (1980) 0.91
Increase in tissue concentrations of histamine and 5-hydroxytryptamine following capsaicin treatment of newborn rats. Life Sci (1981) 0.90
Histamine release induced by compound 48-80 from isolated rat cells: dependence on endogenous ATP. Acta Pharmacol Toxicol (Copenh) (1974) 0.89
In vitro activities of some synthetic substance P analogs. Arch Int Pharmacodyn Ther (1979) 0.87
Properties and possible significance of substance P and insulin fibrils. Neurosci Lett (1981) 0.85
The effect of putative peptide neurotransmitters on cutaneous vascular permeability in the rat. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.85
Calcium ionophores and movement of calcium ions following the physiological stimulus to a secretory process. Nature (1973) 6.09
The role of the alkaline earth ions in anaphylactic histamine secretion. J Physiol (1972) 4.03
Parameters of helix-coil transition theory for alanine-based peptides of varying chain lengths in water. Biopolymers (1991) 3.51
Tests of the helix dipole model for stabilization of alpha-helices. Nature (1987) 3.19
The relationship between histamine secretion and 45calcium uptake by mast cells. J Physiol (1977) 3.02
Competitive antagonists of bradykinin. Peptides (1985) 2.91
Calorimetric determination of the enthalpy change for the alpha-helix to coil transition of an alanine peptide in water. Proc Natl Acad Sci U S A (1991) 2.84
Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions. Proc Natl Acad Sci U S A (1988) 2.57
Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin. J Physiol (1983) 2.42
Human basophil degranulation is not triggered by very dilute antiserum against human IgE. Nature (1993) 2.34
Cromoglycate and other antiallergic drugs: a possible mechanism of action. Br Med J (1976) 2.13
Nature of the charged-group effect on the stability of the C-peptide helix. Proc Natl Acad Sci U S A (1985) 2.09
Urea unfolding of peptide helices as a model for interpreting protein unfolding. Proc Natl Acad Sci U S A (1995) 2.01
Kinetics of amide proton exchange in helical peptides of varying chain lengths. Interpretation by the Lifson-Roig equation. Biochemistry (1992) 1.97
Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors. Br J Pharmacol (1988) 1.96
Indications for surgery in tracheobronchial ruptures. Eur J Cardiothorac Surg (2001) 1.86
A possible role for cyclic AMP in the regulation of histamine secretion and the action of cromoglycate. Biochem Pharmacol (1975) 1.80
Mutations in FGFR1 and FGFR2 cause familial and sporadic Pfeiffer syndrome. Hum Mol Genet (1995) 1.76
Desensitization in the process of histamine secretion induced by antigen and dextran. J Physiol (1974) 1.74
Two bradykinin binding sites with picomolar affinities. J Pharmacol Exp Ther (1986) 1.71
Evaluation of a commercially available enzyme-linked immunosorbent assay for Giardia lamblia antigen in stool. J Clin Microbiol (1991) 1.70
Oral-facial-digital syndrome type VI (Váradi syndrome): further clinical delineation. Am J Med Genet (1990) 1.66
Further studies of the helix dipole model: effects of a free alpha-NH3+ or alpha-COO- group on helix stability. Proteins (1989) 1.63
Once-daily amoxicillin versus twice-daily penicillin V in group A beta-haemolytic streptococcal pharyngitis. Arch Dis Child (2008) 1.59
Peptides and neurogenic inflammation. Br Med Bull (1987) 1.51
Induction of calcium flux across the rat mast cell membrane by bridging IgE receptors. Proc Natl Acad Sci U S A (1979) 1.47
Early enteral feeding compared with parenteral nutrition after oesophageal or oesophagogastric resection and reconstruction. Br J Nutr (2005) 1.44
Effect of flavone inhibitors of transport ATPases on histamine secretion from rat mast cells. Nature (1977) 1.43
The ability of thapsigargin and thapsigargicin to activate cells involved in the inflammatory response. Br J Pharmacol (1985) 1.40
Induction of histamine secretion by polycations. Biochim Biophys Acta (1980) 1.39
Use of pooled formalin-preserved fecal specimens to detect Giardia lamblia. J Clin Microbiol (1991) 1.38
Effects of bradykinin and angiotensin II on intracellular Ca2+ dynamics in endothelial cells. Am J Physiol (1987) 1.38
Quercetin: a novel inhibitor of Ca2+ influx and exocytosis in rat peritoneal mast cells. Biochim Biophys Acta (1977) 1.37
Declining CD4+ T-lymphocyte counts are associated with increased risk of enteric parasitosis and chronic diarrhea: results of a 3-year longitudinal study. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 1.36
Radial artery cannulation. A prospective study in patients undergoing cardiothoracic surgery. Br J Anaesth (1980) 1.34
The action of lanthanum and manganese on anaphylactic histamine secretion. Br J Pharmacol (1973) 1.34
The pharmacological control of immediate hypersensitivity. Annu Rev Pharmacol Toxicol (1981) 1.33
Receptors mediating tachykinin-induced contractile responses in guinea-pig trachea. Br J Pharmacol (1991) 1.33
New synthetic antagonists of bradykinin. Br J Pharmacol (1987) 1.33
Design and synthesis of a peptide having chymotrypsin-like esterase activity. Science (1990) 1.33
Inactivation of bradykinin in the pulmonary circulation. Biochem J (1968) 1.31
Permeation and gating properties of the L-type calcium channel in mouse pancreatic beta cells. J Gen Physiol (1993) 1.30
Release of acetylcholine and 14 C-glycine from the cat spinal cord in vivo. Br J Pharmacol (1971) 1.30
Antinociceptive effects of bradykinin antagonists. Eur J Pharmacol (1987) 1.29
Substance P and analgesia. Nature (1976) 1.27
Proceedings: Activation of anaphylactic histamine release by calcium and strontium ions. Br J Pharmacol (1972) 1.26
Absent IgA and deletions of chromosome 18. J Med Genet (1970) 1.26
Receptor-selective, peptidase-resistant agonists at neurokinin NK-1 and NK-2 receptors: new tools for investigating neurokinin function. Neuropeptides (1991) 1.24
Microplate assay analysis of the distribution of organophosphate and carbamate resistance in Guatemalan Anopheles albimanus. Bull World Health Organ (1988) 1.24
The interaction of calcium and strontium with phosphatidyl serine in the anaphylactic secretion of histamine. J Physiol (1973) 1.23
[3H]Bradykinin receptor binding in mammalian tissue membranes. Proc Natl Acad Sci U S A (1981) 1.21
Movement of strontium ions into mast cells and its relationship to the secretory response. J Physiol (1977) 1.21
Effect of calcium on dextran-induced histamine release from isolated mast cells. Br J Pharmacol (1972) 1.19
Site of action of the antiallergic drugs cromoglycate and doxantrazole [proceedings]. Br J Pharmacol (1977) 1.18
Pharmacological characterization of 5-hydroxytryptamine-induced hyperpolarization of the rat superior cervical ganglion. Br J Pharmacol (1987) 1.18
Side-chain interactions in the C-peptide helix: Phe 8 ... His 12+. Biopolymers (1990) 1.16
Acoustic rhinometry compared with posterior rhinomanometry in the measurement of histamine- and bradykinin-induced changes in nasal airway patency. Br J Clin Pharmacol (1994) 1.15
Submucous cleft palate. Its incidence, natural history, and indications for treatment. Plast Reconstr Surg (1972) 1.15
The effect of kinin agonists and antagonists on the pain response of the human blister base. Naunyn Schmiedebergs Arch Pharmacol (1987) 1.15
Improved stereological techniques for studying myocardial cell growth: application to external sarcolemma, T system, and intercalated disks of rabbit and rat hearts. J Ultrastruct Res (1978) 1.15
Temperature modulation of alpha- and beta-adrenoceptors in the isolated frog heart. Br J Pharmacol (1970) 1.15
Hydrolysis of bradykinin and its higher homologues by angiotensin-converting enzyme. Biochem J (1974) 1.13
A p-methylbenzhydrylamine resin for improved solid-phase synthesis of peptide amides. Peptides (1981) 1.13
Potent and highly selective neurokinin antagonists. J Med Chem (1990) 1.13
Structure-activity relationships in bradykinin analogues. Fed Proc (1990) 1.12
Familial caudal regression anomalad and maternal diabetes. J Med Genet (1979) 1.11
Proceedings: 45-Calcium uptake in rat peritoneal mast cells. Br J Pharmacol (1975) 1.09
Instrument for automated synthesis of peptides. Anal Chem (1966) 1.09
Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain. Eur J Pharmacol (1987) 1.09
1H NMR studies of the solution conformations of an analogue of the C-peptide of ribonuclease A. Biochemistry (1989) 1.08
Rapid determination of the neurotoxin lolitrem B in perennial ryegrass by high-performance liquid chromatography with fluorescence detection. J Chromatogr (1985) 1.07
Immunochemical studies on tobacco mosaic virus protein. IV. The automated solid-phase synthesis of a decapeptide of tobacco mosaic virus protein and its reaction with antibodies to the whole protein. Biochemistry (1966) 1.06
Ring 20 chromosome in a child with seizures, minor anomalies, and retardation. Arch Dis Child (1979) 1.05
Low-density lipoprotein metabolism in mice with soft tissue tumours. Biochim Biophys Acta (1984) 1.04
Guanine nucleotide-dependent, pertussis toxin-insensitive regulation of phosphoinositide turnover by bradykinin in bovine pulmonary artery endothelial cells. FASEB J (1989) 1.04
Metabolism of angiotensin I in the pulmonary circulation. Biochem J (1970) 1.04
Dual effect of lanthanum on histamine release from mast cells. Nat New Biol (1972) 1.03
A study of [D-Pro2, D-Phe7, D-Trp9]-substance P and [D-Trp7,9]-substance P as tachykinin partial agonists in the rat colon. Br J Pharmacol (1984) 1.03
Some effects of calcitonin gene-related peptide in human skin and on histamine release. Br J Dermatol (1986) 1.03
Substance P and beta-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma. J Allergy Clin Immunol (1992) 1.02
Distribution of the DNA and the DNA-histone antigens in the nuclei of free-living and parasitic Sarcomastigophora. J Protozool (1967) 1.02
A study of the histamine H2-receptor mediating relaxation of the parenchymal lung strip preparation of the guinea-pig. Br J Pharmacol (1985) 1.02
Histamine release induced by histone and phorbol ester from rat peritoneal mast cells. Eur J Pharmacol (1985) 1.00
Early histological features of small intestinal injury induced by indomethacin. Aliment Pharmacol Ther (1993) 1.00
The stimulation of IL-2 production by anti-rheumatic drugs. Immunology (1989) 1.00
All-D-bradykinin and the problem of peptide antimetabolites. Nature (1965) 0.99
Conversion of a gonadotropin-releasing hormone antagonist to an agonist. Nature (1982) 0.99
Helix propensities of basic amino acids increase with the length of the side-chain. J Mol Biol (1996) 0.98
Substance P and calcitonin gene-related peptide: effects on mast cells and in human skin. Int Arch Allergy Appl Immunol (1987) 0.98
Evolution of a novel series of [(N,N-dimethylamino)propyl]- and piperazinylbenzanilides as the first selective 5-HT1D antagonists. J Med Chem (1994) 0.98
Efficacy and safety of bisacodyl in the acute treatment of constipation: a double-blind, randomized, placebo-controlled study. Aliment Pharmacol Ther (2006) 0.97
Vasodepressor role of endogenous bradykinin assessed by a bradykinin antagonist. Hypertension (1986) 0.97
Formation of angiotensin III by angiotensin-converting enzyme. Biochem J (1976) 0.96
Differential expression of SNAP-25 isoforms and SNAP-23 in the adrenal gland. J Neurochem (1999) 0.96
Importance of the carboxyl end of bradykinin and other peptides. Nature (1965) 0.96
Relative activities of substance P-related peptides in the guinea-pig ileum and rat parotid gland, in vitro. Br J Pharmacol (1982) 0.96
Inhibitors of nitric oxide synthase in human skin. J Invest Dermatol (1996) 0.96